Laurie H. Glimcher, MD, Selected for STAT's 2024 STATUS List
Dana-Farber Researchers Receive AACR 2024 Scientific Achievement Awards
Dana-Farber CEO Laurie Glimcher Has Always Been a Trail-Blazer and a Risk-Taker
Antibody-Drug Conjugates: A Cancer Therapy Revolution
Preserving Laryngeal Structure and Function for Patients with Cancer
Roswell Park Comprehensive Cancer Center, Generate:Biomedicines Enter Into Collaboration Agreement to Accelerate Novel Cell Therapies For Oncology Using Generative AI
Inspiring Residents to Climb Higher
Cedars-Sinai Cancer Releases 2024 Annual Report
Immunotherapy for Cancer: What it Is, How it Works, and Where it’s Going
Miami Cancer Institute Leads First-in-World Brain Metastasis Trial
Miami Cancer Institute Publication Analyzes Role of Tissue-Agnostic Therapies for the Treatment of Primary Brain Tumors
Advanced Prostate Cancer: Genetic Testing an Invaluable Tool
Clinical Trial Evaluates Triple-Drug Regimen for Patients Newly Diagnosed with FLT3-Mutated AML
Simple Blood Protein Tests Predict Which Lymphoma Patients Are Most Likely to Have Poor CAR T Outcomes
Melanoma Vaccine: Progress and Possibility
Showing 181 - 195 of 987 results
Previous| 1... 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 ...66 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
